Replies to post #405255 on NorthWest Biotherapeutics Inc (NWBO)

[survivor1x]

I keep going back to this.

Yes this leaves out some patients whose metheylation status was not known. It also includes the entire blended population including placebo's. Interestingly enough it is just under 90% close to the number of patients that received DCVAX at some point in time.

Anyway, So that you can follow along I combined the meth and unmeth by multiplying their percentage of total patients(n=293=131+162) by the percentage alive so I could get the total percentage of patients alive at 2 and 3 years of these total 293 patients.

When compared to the Optune trial we beat the TMZ arm and even the treatment arm at 2 and 3 years. 47.8(dcvax) vs 43%(Optune) or 31%(TMZ) and 29.8% vs 26% or 19% for 3 year. The 3 year was shown on another slide by Optune. So we beat 2 and 3 year treatment arm Optune (with blended results) and will probably at least triple the 5% TMZ mark at 5 years in my opinion.